<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:d1f99b0e-44dc-45b5-bb92-698b5d76f9ca,g:b27d8230-7330-4747-8b3a-0d27b7b1435a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://darebioscience.com/role/CoverPage" xlink:type="simple" xlink:href="dare-20200630.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="dare-20200630.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_fa51dc0b-90e0-48a6-b6c5-fe384639cc49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f45c7108-d1a3-4b6f-a077-26684f69b08d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fa51dc0b-90e0-48a6-b6c5-fe384639cc49" xlink:to="loc_us-gaap_AssetsCurrent_f45c7108-d1a3-4b6f-a077-26684f69b08d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_17354e28-e3bb-4459-9636-ad604a76ad12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fa51dc0b-90e0-48a6-b6c5-fe384639cc49" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_17354e28-e3bb-4459-9636-ad604a76ad12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_b0c82580-ca33-446e-b53d-1be988513425" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fa51dc0b-90e0-48a6-b6c5-fe384639cc49" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_b0c82580-ca33-446e-b53d-1be988513425" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4a234fb7-87ce-4acc-9713-b077a41e981c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e5fad690-eeb4-4d4b-92a1-d2f0b76ec603" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4a234fb7-87ce-4acc-9713-b077a41e981c" xlink:to="loc_us-gaap_LiabilitiesCurrent_e5fad690-eeb4-4d4b-92a1-d2f0b76ec603" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_30a07b88-94e1-417b-84bf-76a4d4ae72e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4a234fb7-87ce-4acc-9713-b077a41e981c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_30a07b88-94e1-417b-84bf-76a4d4ae72e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_aa2f7365-d407-4151-b8ea-497e7c6c2cff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4a234fb7-87ce-4acc-9713-b077a41e981c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_aa2f7365-d407-4151-b8ea-497e7c6c2cff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ce390943-e60c-4f50-9fd3-5e16a8d64297" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4a234fb7-87ce-4acc-9713-b077a41e981c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ce390943-e60c-4f50-9fd3-5e16a8d64297" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_3f09580f-1b8b-408d-835a-3d035f75f77e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_af795811-190f-4a0a-93e4-1331112e0156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3f09580f-1b8b-408d-835a-3d035f75f77e" xlink:to="loc_us-gaap_Liabilities_af795811-190f-4a0a-93e4-1331112e0156" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_ea8b94c3-8260-424f-8109-8c2d5feff600" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3f09580f-1b8b-408d-835a-3d035f75f77e" xlink:to="loc_us-gaap_CommitmentsAndContingencies_ea8b94c3-8260-424f-8109-8c2d5feff600" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f9f28f39-d3b5-4075-8a70-1bcb25fa96a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3f09580f-1b8b-408d-835a-3d035f75f77e" xlink:to="loc_us-gaap_StockholdersEquity_f9f28f39-d3b5-4075-8a70-1bcb25fa96a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d02e1cd8-678c-448e-91f1-77a10ed39bdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_ab74b626-15ca-48de-8d11-cbeeca1f757f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d02e1cd8-678c-448e-91f1-77a10ed39bdf" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_ab74b626-15ca-48de-8d11-cbeeca1f757f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_2abee534-40d6-4663-8f61-e3d5983939e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d02e1cd8-678c-448e-91f1-77a10ed39bdf" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_2abee534-40d6-4663-8f61-e3d5983939e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_541b948a-f446-4d98-b0b1-2ee8cdde63ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d02e1cd8-678c-448e-91f1-77a10ed39bdf" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_541b948a-f446-4d98-b0b1-2ee8cdde63ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9066ac6c-cd6b-40a4-a2d4-b81c978c1a24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_aaa5a82f-785a-41c9-a10c-d9e2ebd4b8f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9066ac6c-cd6b-40a4-a2d4-b81c978c1a24" xlink:to="loc_us-gaap_PreferredStockValue_aaa5a82f-785a-41c9-a10c-d9e2ebd4b8f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_2c56ffa4-6caa-4f43-ad5e-7fff77794082" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9066ac6c-cd6b-40a4-a2d4-b81c978c1a24" xlink:to="loc_us-gaap_CommonStockValue_2c56ffa4-6caa-4f43-ad5e-7fff77794082" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5d4f8c10-6169-4858-9566-832ad49725d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9066ac6c-cd6b-40a4-a2d4-b81c978c1a24" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5d4f8c10-6169-4858-9566-832ad49725d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_64c1625a-f4ea-4d2c-bd4c-6e10eb5dc776" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9066ac6c-cd6b-40a4-a2d4-b81c978c1a24" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_64c1625a-f4ea-4d2c-bd4c-6e10eb5dc776" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_07be4f87-6856-4941-afda-804418f8d89e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9066ac6c-cd6b-40a4-a2d4-b81c978c1a24" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_07be4f87-6856-4941-afda-804418f8d89e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6f392d05-7897-4803-b4d3-39c100f1e7de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_2939084c-94c5-415d-9497-a0c84a1199bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6f392d05-7897-4803-b4d3-39c100f1e7de" xlink:to="loc_us-gaap_AccountsPayableCurrent_2939084c-94c5-415d-9497-a0c84a1199bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f57b755d-fd33-44b7-b731-406e0b467303" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6f392d05-7897-4803-b4d3-39c100f1e7de" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_f57b755d-fd33-44b7-b731-406e0b467303" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_DeferredGrantFundingCurrent_872a01d2-af3b-44d9-880b-e0e8e1599cd1" xlink:href="dare-20200630.xsd#dare_DeferredGrantFundingCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6f392d05-7897-4803-b4d3-39c100f1e7de" xlink:to="loc_dare_DeferredGrantFundingCurrent_872a01d2-af3b-44d9-880b-e0e8e1599cd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_40ccf3f9-0aa4-4266-8378-eca57192fafb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6f392d05-7897-4803-b4d3-39c100f1e7de" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_40ccf3f9-0aa4-4266-8378-eca57192fafb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_aa2940bd-0484-4b5c-a1f4-f54909f47750" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6f392d05-7897-4803-b4d3-39c100f1e7de" xlink:to="loc_us-gaap_NotesPayableCurrent_aa2940bd-0484-4b5c-a1f4-f54909f47750" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="dare-20200630.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="dare-20200630.xsd#ConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1098db30-129e-4918-b3f4-f914af02b963" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ae596ef5-25a6-4f0c-97ad-c802d2b2779b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1098db30-129e-4918-b3f4-f914af02b963" xlink:to="loc_us-gaap_NetIncomeLoss_ae596ef5-25a6-4f0c-97ad-c802d2b2779b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount_d4a7bb07-64fe-4745-bd83-9fa4132a637c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1098db30-129e-4918-b3f4-f914af02b963" xlink:to="loc_us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount_d4a7bb07-64fe-4745-bd83-9fa4132a637c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0c364cdf-3fc7-4abd-913a-dc1090731595" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d08b4b80-7892-41af-85ff-489569a53f0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0c364cdf-3fc7-4abd-913a-dc1090731595" xlink:to="loc_us-gaap_OperatingIncomeLoss_d08b4b80-7892-41af-85ff-489569a53f0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d9079592-faa1-40b9-a188-77252269f1ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0c364cdf-3fc7-4abd-913a-dc1090731595" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d9079592-faa1-40b9-a188-77252269f1ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_99ade238-fe01-4007-8806-e5b295e33a0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_6a0a8591-45dc-480a-bfa2-2b86b4a4b85c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_99ade238-fe01-4007-8806-e5b295e33a0c" xlink:to="loc_us-gaap_OperatingExpenses_6a0a8591-45dc-480a-bfa2-2b86b4a4b85c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_63de859c-e83f-4483-ad1d-776f0786769b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_ced7bb78-3a70-42a4-bceb-7d8d2e053071" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_63de859c-e83f-4483-ad1d-776f0786769b" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_ced7bb78-3a70-42a4-bceb-7d8d2e053071" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d63e82db-09af-45b7-8630-b062fd09d117" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_63de859c-e83f-4483-ad1d-776f0786769b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d63e82db-09af-45b7-8630-b062fd09d117" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_LicenseFee_a91c6f8e-db4f-41dc-85bb-da8235397239" xlink:href="dare-20200630.xsd#dare_LicenseFee"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_63de859c-e83f-4483-ad1d-776f0786769b" xlink:to="loc_dare_LicenseFee_a91c6f8e-db4f-41dc-85bb-da8235397239" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_3219446a-11e5-4bef-9b59-c61a663d984e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4ad9fc16-eb2f-4d3d-86e3-aaaf7ab3cfec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_3219446a-11e5-4bef-9b59-c61a663d984e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4ad9fc16-eb2f-4d3d-86e3-aaaf7ab3cfec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_fd9ce05c-22e3-40f8-9b22-23a0f6c0770d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_3219446a-11e5-4bef-9b59-c61a663d984e" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_fd9ce05c-22e3-40f8-9b22-23a0f6c0770d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="dare-20200630.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="dare-20200630.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7b8698b5-25f8-4d6a-b3c0-6a3ca5be66fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_556e0f35-8970-4111-8401-a3a60f3ebfdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7b8698b5-25f8-4d6a-b3c0-6a3ca5be66fa" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_556e0f35-8970-4111-8401-a3a60f3ebfdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bdac26cf-4244-4500-a80a-1b8233ef9b3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7b8698b5-25f8-4d6a-b3c0-6a3ca5be66fa" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bdac26cf-4244-4500-a80a-1b8233ef9b3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_2cfefee4-a32f-4512-8985-21892be962c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7b8698b5-25f8-4d6a-b3c0-6a3ca5be66fa" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_2cfefee4-a32f-4512-8985-21892be962c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28ef55ef-68b1-45fa-b884-9902d7ac4171" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7b8698b5-25f8-4d6a-b3c0-6a3ca5be66fa" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28ef55ef-68b1-45fa-b884-9902d7ac4171" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b21a341b-34be-4b7f-92c8-441065f56d41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_cd16b3bb-4d1a-4605-bdd5-253e48a7f77b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b21a341b-34be-4b7f-92c8-441065f56d41" xlink:to="loc_us-gaap_ProfitLoss_cd16b3bb-4d1a-4605-bdd5-253e48a7f77b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_61244bac-185d-4265-b9a3-1a74ce322d97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b21a341b-34be-4b7f-92c8-441065f56d41" xlink:to="loc_us-gaap_Depreciation_61244bac-185d-4265-b9a3-1a74ce322d97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_fae44186-fc41-4cb5-adf7-d974c67bf743" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b21a341b-34be-4b7f-92c8-441065f56d41" xlink:to="loc_us-gaap_ShareBasedCompensation_fae44186-fc41-4cb5-adf7-d974c67bf743" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_6c13798f-fbae-4ae5-9579-0c4c559d6d64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b21a341b-34be-4b7f-92c8-441065f56d41" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_6c13798f-fbae-4ae5-9579-0c4c559d6d64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_f3ccdb35-575e-4bbc-bc70-4a2218c2f5f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b21a341b-34be-4b7f-92c8-441065f56d41" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_f3ccdb35-575e-4bbc-bc70-4a2218c2f5f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_IncreaseDecreaseInOtherNonCurrentAssetsAndDeferredCharges_26069a4a-3142-4488-ba5b-b8410852115a" xlink:href="dare-20200630.xsd#dare_IncreaseDecreaseInOtherNonCurrentAssetsAndDeferredCharges"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b21a341b-34be-4b7f-92c8-441065f56d41" xlink:to="loc_dare_IncreaseDecreaseInOtherNonCurrentAssetsAndDeferredCharges_26069a4a-3142-4488-ba5b-b8410852115a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_787f644d-e575-4222-9477-0903323b3508" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b21a341b-34be-4b7f-92c8-441065f56d41" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_787f644d-e575-4222-9477-0903323b3508" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_6c5ff7b2-b51c-4402-9ee3-d024ec49e0ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b21a341b-34be-4b7f-92c8-441065f56d41" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_6c5ff7b2-b51c-4402-9ee3-d024ec49e0ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_17ce38b9-95c4-45f9-82b0-7c13c32e4479" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b21a341b-34be-4b7f-92c8-441065f56d41" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_17ce38b9-95c4-45f9-82b0-7c13c32e4479" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_NonCashLeaseExpense_3f1bbc22-5fc5-4a7d-9839-24d3eae9516c" xlink:href="dare-20200630.xsd#dare_NonCashLeaseExpense"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b21a341b-34be-4b7f-92c8-441065f56d41" xlink:to="loc_dare_NonCashLeaseExpense_3f1bbc22-5fc5-4a7d-9839-24d3eae9516c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_IncreaseDecreaseInDeferredGrantFunding_93e69588-efb6-425f-98a5-0b2773610294" xlink:href="dare-20200630.xsd#dare_IncreaseDecreaseInDeferredGrantFunding"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b21a341b-34be-4b7f-92c8-441065f56d41" xlink:to="loc_dare_IncreaseDecreaseInDeferredGrantFunding_93e69588-efb6-425f-98a5-0b2773610294" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d811c914-cb6c-4477-8ace-915e6ad94ff1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_NetProceedsFromIssuanceOfCommonStockAndWarrants_f08bc9be-b6ab-41e8-899f-7ab5f24c0b82" xlink:href="dare-20200630.xsd#dare_NetProceedsFromIssuanceOfCommonStockAndWarrants"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d811c914-cb6c-4477-8ace-915e6ad94ff1" xlink:to="loc_dare_NetProceedsFromIssuanceOfCommonStockAndWarrants_f08bc9be-b6ab-41e8-899f-7ab5f24c0b82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dare_ProceedsFromIssuanceOfCommonStockAndWarrants_d8a05d50-c092-4f55-84a7-ecb187761bed" xlink:href="dare-20200630.xsd#dare_ProceedsFromIssuanceOfCommonStockAndWarrants"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d811c914-cb6c-4477-8ace-915e6ad94ff1" xlink:to="loc_dare_ProceedsFromIssuanceOfCommonStockAndWarrants_d8a05d50-c092-4f55-84a7-ecb187761bed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_2c575e18-dd5b-4cc1-a914-8e9a6f24e325" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d811c914-cb6c-4477-8ace-915e6ad94ff1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_2c575e18-dd5b-4cc1-a914-8e9a6f24e325" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_e3b6442f-dcbd-449a-b517-0c9705abaded" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d811c914-cb6c-4477-8ace-915e6ad94ff1" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_e3b6442f-dcbd-449a-b517-0c9705abaded" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f4efdd83-221d-4320-ad46-024ad7e5c879" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ccf3c335-6979-4255-b731-58ebec1c4b8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f4efdd83-221d-4320-ad46-024ad7e5c879" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ccf3c335-6979-4255-b731-58ebec1c4b8a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/OrganizationandDescriptionoftheBusiness" xlink:type="simple" xlink:href="dare-20200630.xsd#OrganizationandDescriptionoftheBusiness"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/OrganizationandDescriptionoftheBusiness" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/OrganizationandDescriptionoftheBusinessAdditionalInformationDetails" xlink:type="simple" xlink:href="dare-20200630.xsd#OrganizationandDescriptionoftheBusinessAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/OrganizationandDescriptionoftheBusinessAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="dare-20200630.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="dare-20200630.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="dare-20200630.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/SummaryofSignificantAccountingPoliciesFinancialAssetsandLiabilitiesRemeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="dare-20200630.xsd#SummaryofSignificantAccountingPoliciesFinancialAssetsandLiabilitiesRemeasuredonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/SummaryofSignificantAccountingPoliciesFinancialAssetsandLiabilitiesRemeasuredonaRecurringBasisDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="dare-20200630.xsd#SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/LicenseandCollaborationAgreements" xlink:type="simple" xlink:href="dare-20200630.xsd#LicenseandCollaborationAgreements"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/LicenseandCollaborationAgreements" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/LicenseandCollaborationAgreementsAdditionalInformationDetails" xlink:type="simple" xlink:href="dare-20200630.xsd#LicenseandCollaborationAgreementsAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/LicenseandCollaborationAgreementsAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/Acquisition" xlink:type="simple" xlink:href="dare-20200630.xsd#Acquisition"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/Acquisition" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/AcquisitionAdditionalInformationDetails" xlink:type="simple" xlink:href="dare-20200630.xsd#AcquisitionAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/AcquisitionAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="dare-20200630.xsd#StockBasedCompensation"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/StockBasedCompensation" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="dare-20200630.xsd#StockBasedCompensationTables"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/StockBasedCompensationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/StockBasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="dare-20200630.xsd#StockBasedCompensationAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/StockBasedCompensationAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/StockBasedCompensationSummaryofStockOptionActivityforAmended2014PlanandRelatedInformationDetails" xlink:type="simple" xlink:href="dare-20200630.xsd#StockBasedCompensationSummaryofStockOptionActivityforAmended2014PlanandRelatedInformationDetails"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/StockBasedCompensationSummaryofStockOptionActivityforAmended2014PlanandRelatedInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/StockBasedCompensationSummaryofRecognizedStockBasedCompensationExpenseRelatedtoStockOptionsGrantedtoEmployeesandDirectorsDetails" xlink:type="simple" xlink:href="dare-20200630.xsd#StockBasedCompensationSummaryofRecognizedStockBasedCompensationExpenseRelatedtoStockOptionsGrantedtoEmployeesandDirectorsDetails"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/StockBasedCompensationSummaryofRecognizedStockBasedCompensationExpenseRelatedtoStockOptionsGrantedtoEmployeesandDirectorsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/StockBasedCompensationSummaryofAssumptionsUsedinBlackScholesOptionPricingModelforStockOptionsGrantedtoEmployeesandDirectorsDetails" xlink:type="simple" xlink:href="dare-20200630.xsd#StockBasedCompensationSummaryofAssumptionsUsedinBlackScholesOptionPricingModelforStockOptionsGrantedtoEmployeesandDirectorsDetails"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/StockBasedCompensationSummaryofAssumptionsUsedinBlackScholesOptionPricingModelforStockOptionsGrantedtoEmployeesandDirectorsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/StockholdersEquity" xlink:type="simple" xlink:href="dare-20200630.xsd#StockholdersEquity"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/StockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="dare-20200630.xsd#StockholdersEquityTables"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/StockholdersEquityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="dare-20200630.xsd#StockholdersEquityAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/StockholdersEquityScheduleofCommonStockWarrantsOutstandingDetails" xlink:type="simple" xlink:href="dare-20200630.xsd#StockholdersEquityScheduleofCommonStockWarrantsOutstandingDetails"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/StockholdersEquityScheduleofCommonStockWarrantsOutstandingDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/LeasedProperties" xlink:type="simple" xlink:href="dare-20200630.xsd#LeasedProperties"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/LeasedProperties" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/LeasedPropertiesTables" xlink:type="simple" xlink:href="dare-20200630.xsd#LeasedPropertiesTables"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/LeasedPropertiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/LeasedPropertiesAdditionalInformationDetails" xlink:type="simple" xlink:href="dare-20200630.xsd#LeasedPropertiesAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/LeasedPropertiesAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/LeasedPropertiesFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="dare-20200630.xsd#LeasedPropertiesFutureMinimumLeasePaymentsDetails"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/LeasedPropertiesFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_003bb65d-8c4e-4f75-89c4-2f9702a0cf20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ea5cada9-1766-40c6-bc8e-27e9473b8cfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_003bb65d-8c4e-4f75-89c4-2f9702a0cf20" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ea5cada9-1766-40c6-bc8e-27e9473b8cfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_887c035a-d806-4ddd-9e4b-5517f462b714" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_003bb65d-8c4e-4f75-89c4-2f9702a0cf20" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_887c035a-d806-4ddd-9e4b-5517f462b714" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_9869c324-f7aa-49c8-a382-8b5c5d21f709" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_003bb65d-8c4e-4f75-89c4-2f9702a0cf20" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_9869c324-f7aa-49c8-a382-8b5c5d21f709" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/LeasedPropertiesFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="dare-20200630.xsd#LeasedPropertiesFutureMinimumLeasePaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/LeasedPropertiesFutureMinimumLeasePaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f690132d-7b3b-4b10-ac4b-88872c186ac9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_88408c53-448a-4f40-aa1c-b9c748cb4e2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f690132d-7b3b-4b10-ac4b-88872c186ac9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_88408c53-448a-4f40-aa1c-b9c748cb4e2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_f4396cc5-09ac-4625-8957-101333315726" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f690132d-7b3b-4b10-ac4b-88872c186ac9" xlink:to="loc_us-gaap_OperatingLeaseLiability_f4396cc5-09ac-4625-8957-101333315726" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://darebioscience.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="dare-20200630.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="simple" xlink:href="dare-20200630.xsd#CommitmentsandContingenciesAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/GrantAward" xlink:type="simple" xlink:href="dare-20200630.xsd#GrantAward"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/GrantAward" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/GrantAwardAdditionalInformationDetails" xlink:type="simple" xlink:href="dare-20200630.xsd#GrantAwardAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/GrantAwardAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/NetLossPerShare" xlink:type="simple" xlink:href="dare-20200630.xsd#NetLossPerShare"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/NetLossPerShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/NetLossPerShareTables" xlink:type="simple" xlink:href="dare-20200630.xsd#NetLossPerShareTables"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/NetLossPerShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/NetLossPerSharePotentialDilutiveOutstandingSecuritiesExcludedFromDilutedNetLossPerCommonShareDetails" xlink:type="simple" xlink:href="dare-20200630.xsd#NetLossPerSharePotentialDilutiveOutstandingSecuritiesExcludedFromDilutedNetLossPerCommonShareDetails"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/NetLossPerSharePotentialDilutiveOutstandingSecuritiesExcludedFromDilutedNetLossPerCommonShareDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/SubsequentEvents" xlink:type="simple" xlink:href="dare-20200630.xsd#SubsequentEvents"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/SubsequentEvents" xlink:type="extended"/>
  <link:roleRef roleURI="http://darebioscience.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="dare-20200630.xsd#SubsequentEventsDetails"/>
  <link:calculationLink xlink:role="http://darebioscience.com/role/SubsequentEventsDetails" xlink:type="extended"/>
</link:linkbase>
